12:55 AM EDT, 05/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our 12-month price target of $13, based on 6.5x our FY 26 (Jan.) EPS estimate and between the company's three- and five-year average forward P/E multiples. We lower our FY 26 EPS estimate by $0.20 to $2.00 and maintain our FY 27 EPS estimate of $2.10. M posted normalized FQ1 EPS of $0.16 vs. $0.27, $0.01 above consensus estimates on revenues of $4.8B vs. $5.0B and $172M above estimates. By brand in FQ1, Macy's revenues declined 6.5% Y/Y, Bloomingdale's increased 2.6%, and Bluemercury increased 0.8%. FQ1 gross margin of 39.2% was flat Y/Y due to improved merchandise margin offset by higher delivery expense. The company continued to tightly manage inventory and boasts a solid balance sheet with $932M in cash and $2.8B in long-term debt. Macy's maintained its full-year revenue guidance while lowering its profitability outlook and now expects EPS between $1.60 and $2.00, down from the previous range of between $2.05 and $2.25. We believe shares are fairly valued at current levels.